Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference4%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.